Adverse event reporting in adult intensive care units and the impact of a multifaceted intervention on drug-related adverse events

被引:26
|
作者
Pagnamenta, Alberto [1 ,2 ]
Rabito, Giovanni [3 ]
Arosio, Alessandra [3 ]
Perren, Andreas [1 ,2 ]
Malacrida, Roberto [1 ,2 ]
Barazzoni, Fabrizio [4 ]
Domenighetti, Guido [1 ,2 ]
机构
[1] EOC, Dept Intens Care Med, Intens Care Units Reg Hosp Mendrisio, Bellinzona, Switzerland
[2] EOC, Dept Intens Care Med, Intens Care Units Reg Hosp Mendrisio, Lugano, Switzerland
[3] Reg Hosp Locarno, Div Qual Improvement & Risk Management, Locarno, Switzerland
[4] EOC, Med Area Unit, Bellinzona, Switzerland
来源
ANNALS OF INTENSIVE CARE | 2012年 / 2卷
关键词
Adverse events; Medical errors; Patient safety; Quality improvement; Intensive care; Reliability; PATIENT SAFETY; QUALITY IMPROVEMENT; MEDICATION ERRORS; PHARMACISTS; FRAMEWORK; OUTCOMES;
D O I
10.1186/2110-5820-2-47
中图分类号
R4 [临床医学];
学科分类号
1002 ; 100602 ;
摘要
Background: Adverse events (AEs) frequently occur in intensive care units (ICUs) and affect negatively patient outcomes. Targeted improvement strategies for patient safety are difficult to evaluate because of the intrinsic limitations of reporting crude AE rates. Single interventions influence positively the quality of care, but a multifaceted approach has been tested only in selected cases. The present study was designed to evaluate the rate, types, and contributing factors of emerging AEs and test the hypothesis that a multifaceted intervention on medication might reduce drug-related AEs. Methods: This is a prospective, multicenter, before-and-after study of adult patients admitted to four ICUs during a 24-month period. Voluntary, anonymous, self-reporting of AEs was performed using a detailed, locally designed questionnaire. The temporal impact of a multifaceted implementation strategy to reduce drug-related AEs was evaluated using the risk-index scores methodology. Results: A total of 2,047 AEs were reported (32 events per 100 ICU patient admissions and 117.4 events per 1,000 ICU patient days) from 6,404 patients, totaling 17,434 patient days. Nurses submitted the majority of questionnaires (n = 1,781, 87%). AEs were eye-witnessed in 49% (n = 1,003) of cases and occurred preferentially during an elective procedure (n = 1,597, 78%) and on morning shifts (n = 1,003, 49%), with a peak rate occurring around 10 a. m. Drug-related AEs were the most prevalent (n = 984, 48%), mainly as a consequence of incorrect prescriptions. Poor communication among caregivers (n = 776) and noncompliance with internal guidelines (n = 525) were the most prevalent contributing factors for AE occurrence. The majority of AEs (n = 1155, 56.4%) was associated with minimal, temporary harm. Risk-index scores for drug-related AEs decreased from 10.01 +/- 2.7 to 8.72 +/- 3.52 (absolute risk difference 1.29; 95% confidence interval, 0.88-1.7; p < 0.01) following the introduction of the intervention. Conclusions: AEs occurred in the ICU with a typical diurnal frequency distribution. Medication-related AEs were the most prevalent. By applying the risk-index scores methodology, we were able to demonstrate that our multifaceted implementation strategy focused on medication-related adverse events allowed to decrease drug related incidents.
引用
收藏
页数:10
相关论文
共 50 条
  • [31] Adverse events in the intensive care unit: impact on mortality and length of stay in a prospective study
    Roque, Keroulay Estebanez
    Tonini, Teresa
    Prates Melo, Enirtes Caetano
    CADERNOS DE SAUDE PUBLICA, 2016, 32 (10):
  • [32] A system for the detection, recording and analysis of adverse events: Implementation in intensive care units (ICU-MERIS)
    Vozikis, A.
    Pollalis, Y.
    Riga, M.
    Magina, N.
    Stoufis, N.
    Teneketzi, Z.
    ARCHIVES OF HELLENIC MEDICINE, 2012, 29 (03): : 345 - 353
  • [33] Adverse Events Related to Off-Label Drugs Using Spontaneous Adverse Event Reporting Systems
    Han, Nayoung
    Oh, Jung Mi
    Kim, In-Wha
    THERAPEUTICS AND CLINICAL RISK MANAGEMENT, 2021, 17 : 877 - 887
  • [34] Adverse events related to neuromuscular blocking agents: a disproportionality analysis of the FDA adverse event reporting system
    Li, Liangxia
    Xu, Qianqian
    Liu, Yarui
    Pang, Liangfang
    Cui, Zhou
    Lu, Yuanyuan
    FRONTIERS IN PHARMACOLOGY, 2024, 15
  • [35] Facilitated Nurse Medication-Related Event Reporting to Improve Medication Management Quality and Safety in Intensive Care Units
    Xu, Jie
    Reale, Carrie
    Slagle, Jason M.
    Anders, Shilo
    Shotwell, Matthew S.
    Dresselhaus, Timothy
    Weinger, Matthew B.
    NURSING RESEARCH, 2017, 66 (05) : 337 - 349
  • [36] Adverse drug events caused by three high-risk drug-drug interactions in patients admitted to intensive care units: A multicentre retrospective observational study
    Klopotowska, Joanna E.
    Leopold, Jan-Hendrik
    Bakker, Tinka
    Yasrebi-de Kom, Izak
    Engelaer, Frouke M.
    de Jonge, Evert
    Haspels-Hogervorst, Esther K.
    van den Bergh, Walter M.
    Renes, Maurits H.
    Jong, Bas T.
    Kieft, Hans
    Wieringa, Andre
    Hendriks, Stefaan
    Lau, Cedric
    van Bree, Sjoerd H. W.
    Lammers, Hendrick J. W.
    Wierenga, Peter C.
    Bosman, Rob J.
    de Jong, Vincent M.
    Slijkhuis, Mirjam
    Franssen, Eric J. F.
    Vermeijden, Wytze J.
    Masselink, Joost
    Purmer, Ilse M.
    Bosma, Liesbeth E.
    Hoeksema, Martin
    Wesselink, Elsbeth
    de Lange, Dylan W.
    de Keizer, Nicolette F.
    Dongelmans, Dave A.
    Abu-Hanna, Ameen
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2024, 90 (01) : 164 - 175
  • [37] Patient stratification and identification of adverse event correlations in the space of 1190 drug related adverse events
    Roitmann, Eva
    Eriksson, Robert
    Brunak, Soren
    FRONTIERS IN PHYSIOLOGY, 2014, 5
  • [38] Infection and infestation-related adverse events of biologics in psoriasis: insights from the Food and Drug Administration Adverse Event Reporting System (FAERS)
    Fang, Runan
    Zhou, Yang
    Han, Lu
    Chen, Wenjing
    Sun, Yuan
    Li, Jianhong
    EXPERT OPINION ON DRUG SAFETY, 2024,
  • [39] Adverse Drug Events in U.S. Adult Ambulatory Medical Care
    Sarkar, Urmimala
    Lopez, Andrea
    Maselli, Judith H.
    Gonzales, Ralph
    HEALTH SERVICES RESEARCH, 2011, 46 (05) : 1517 - 1533
  • [40] Theoretical references that support a surveillance system for adverse events in intensive care units
    Perez, Yuliett Mora
    Esperon, Julia Maricela Torres
    Magnago, Tania Solange Bosi de Souza
    Roca, Alfredo Alberto Espinosa
    MEDISUR-REVISTA DE CIENCIAS MEDICAS DE CIENFUEGOS, 2023, 21 (01): : 15 - 23